|

AZD0901 Clinical Trials

3 actively recruiting trials across 3 locations

▼ -1 trial since May 2026

Also known as: CMG901, Sonesitatug Vedotin

Pipeline

Phase 2: 3

Top Sponsors

  • AstraZeneca3

Indications

  • Cancer3
  • Gastric Cancer2
  • Gastroesophageal Adenocarcinoma1
  • Pancreatic Ductal Adenocarcinoma1
  • Biliary Tract Cancer1

Los Angeles, California1 trial

Novel Combinations in Participants With Locally Advanced Unresectable or Metastatic Gastric or Gastroesophageal Junction Adenocarcinoma

Research Site

Phase 2

Orange, California1 trial

AZD0901 in Participants With Advanced Solid Tumours Expressing Claudin18.2

Research Site

Phase 2

Newark, Delaware1 trial

A Study of Novel Agents or Combinations as Perioperative Treatment in Participants With Locally Advanced Resectable Gastroesophageal Adenocarcinoma

Research Site

Phase 2

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.